Biographical note

Dr. Kamil Reza Khondakar is a distinguished researcher with over a decade of experience in interdisciplinary science, combining physics, biomedical engineering, materials science, and artificial intelligence. He completed four years of doctoral training at the University of Queensland, Australia after receiving IPRSS fellowship from Government of Australia. He worked as research fellow for four years at the National Physical Laboratory, India, supported by a prestigious Government of India grant. His research focuses on lab-on-chip technology, microfluidics, biosensors, and point-of-care diagnostics, contributing to over 50 peer-reviewed publications in high-impact journals such as Accounts of Chemical Research, ACS Nano, Advances in Colloid and Interface Science, BMEMat and Biosensors and Bioelectronics, Small, etc. Dr. Kamil has delivered invited lectures in the USA and Australia on lab-on-a-chip technology for cancer detection. He has edited three Elsevier books and serves as an editor for journals: Frontiers in Nanotechnology and Biosensors. As a peer reviewer for top journals and a mentor to young researchers, he plays a vital role in advancing scientific innovation and publishing worldwide. Dr. Ajeet Kaushik is Associate Professor at the NanoBioTech Laboratory, Department of Environmental Engineering, Florida Polytechnic University, USA. He is the recipient of various reputed awards for his service in the area of nano-biotechnology for health care. He has edited seven books, written more than 100 international research peer reviewed publications, and has three patents in the area of nanomedicine and smart biosensors for personalized health care. In the course of his research, Dr. Kaushik has been engaged in the design and development of various electro-active nanostructures for electrochemical biosensor and nanomedicine for health care. His research interests include nanobiotechnology, analytical systems, design and develop nanostructures, nano-carries for drug delivery, nano-therapeutics for CNS diseases, on-demand site-specific release of therapeutic agents, exploring personalized nanomedicines, biosensors, point-of-care sensing devices, and related areas of health care monitoring.